Ueda, Y., H. Ishii, T. Kitano, M. Shindo, H. Miyazawa, K. Ito, K. Hirai, Y. Kaku, H. Mori, T. Hoshino, S. Ookawara, M. Kakei, K. Tabei, and Y. Morishita. “Effects and Safety of Linagliptin As an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin–Angiotensin–Aldosterone System Blockers”. Drug Target Insights, vol. 10, no. 1, Sept. 2016, doi:10.33393/dti.2016.1422.